Amello Jason

CIK 00014518056 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001451805

Recent Transactions

50 trades

Award
TScan Therapeutics, Inc.$TCRX
Stock Option (Right to Buy)
2026-01-20+350,000→ 350,000 total
Award
TScan Therapeutics, Inc.$TCRX
Stock Option (Right to Buy)
2025-01-03+270,000→ 270,000 total
Award
TScan Therapeutics, Inc.$TCRX
Stock Option (Right to Buy)
2024-02-01+750,000→ 750,000 total
Tax Payment
Candel Therapeutics, Inc.$CADL
Common Stock
2023-11-28$0.90/sh−20,153→ 202,009 total
Award
Candel Therapeutics, Inc.$CADL
Common Stock
2023-11-26+125,717→ 222,162 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2023-04-28+90,000→ 90,000 total
Award
Acer Therapeutics Inc.
Stock Option (right to buy)
2023-03-14+20,000→ 20,000 total
Purchase
Candel Therapeutics, Inc.$CADL
Common Stock
2022-12-09$1.93/sh+2,468→ 5,568 total
Purchase
Candel Therapeutics, Inc.$CADL
Common Stock
2022-12-08$1.69/sh+3,100→ 3,100 total
Award
Candel Therapeutics, Inc.$CADL
Common Stock
2022-11-28+90,877→ 90,877 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2022-09-21+230,000→ 230,000 total
Award
Acer Therapeutics Inc.
Stock Option (right to buy)
2022-01-14+18,500→ 18,500 total
Award
Acer Therapeutics Inc.
Stock Option (right to buy)
2021-01-15+15,000→ 15,000 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2020-02-28+30,000→ 151,618 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2020-02-28+45,000→ 45,000 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2020-02-28$8.70/sh−6,976→ 144,642 total
Award
Acer Therapeutics Inc.
Stock Option (right to buy)
2020-01-02+9,000→ 9,000 total
Disposition to Issuer
Akebia Therapeutics, Inc.$AKBA
Common Stock
2019-04-11$7.70/sh−13,148→ 118,618 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2019-02-28+65,000→ 131,766 total
Award
Akebia Therapeutics, Inc.$AKBA
Employee Stock Option (Right to buy)
2019-02-28+100,000→ 100,000 total
Award
Acer Therapeutics Inc.
Employee Stock Option (right to buy)
2019-02-01+6,000→ 6,000 total
Tax Payment
Akebia Therapeutics, Inc.$AKBA
Common Stock
2018-12-12$8.94/sh−22,235→ 66,501 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2018-02-28+19,500→ 87,236 total
Award
Akebia Therapeutics, Inc.$AKBA
Employee Stock Option (Right to buy)
2018-02-28+27,700→ 27,700 total
Award
Acer Therapeutics Inc.
Stock Option (right to buy)
2017-10-04+9,000→ 9,000 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2017-02-21+30,000→ 65,637 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2017-02-21$10.14/sh+47,500→ 47,500 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2016-02-22+26,000→ 33,330 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to Buy)
2016-02-22+39,650→ 39,650 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to Buy)
2015-03-06+45,000→ 45,000 total
Purchase
Akebia Therapeutics, Inc.$AKBA
Common Stock
2014-11-26$13.22/sh+1,000→ 5,000 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to Buy)
2014-05-14+21,667→ 21,667 total
Purchase
Akebia Therapeutics, Inc.$AKBA
Common Stock
2014-03-25$17.00/sh+4,000→ 4,000 total
Tax Payment
Alaunos Therapeutics, Inc.$TCRT
Common Stock
2013-05-08$1.65/sh−2,623→ 22,377 total
Award
Alaunos Therapeutics, Inc.$TCRT
Employee Stock Option (right to buy)
2012-12-31+150,000→ 150,000 total
Award
Alaunos Therapeutics, Inc.$TCRT
Employee Stock Option (right to buy)
2012-06-20+200,000→ 200,000 total
Award
Alaunos Therapeutics, Inc.$TCRT
Common Stock
2012-05-08+25,000→ 25,000 total
Disposition to Issuer
GENZYME CORP
Stock Option (right to buy)
2011-04-04$58.50/sh−8,640→ 0 total
Exercise/Conversion
GENZYME CORP
Genzyme common stock (GENZ)
2011-04-04+1,818→ 3,902 total
Exercise/Conversion
GENZYME CORP
Genzyme common stock (GENZ)
2011-04-04+1,740→ 5,642 total
Disposition from Tender
GENZYME CORP
Genzyme common stock (GENZ)
2011-04-04$74.00/sh−2,084→ 5,005 total
Exercise/Conversion
GENZYME CORP
Restricted Stock Units
2011-04-04−1,818→ 0 total
Exercise/Conversion
GENZYME CORP
Restricted Stock Units
2011-04-04−1,740→ 0 total
Exercise/Conversion
GENZYME CORP
Restricted Stock Units
2011-04-04−1,447→ 0 total
Disposition to Issuer
GENZYME CORP
Stock Option (right to buy)
2011-04-04$58.66/sh−5,455→ 0 total
Disposition to Issuer
GENZYME CORP
Stock Option (right to buy)
2011-04-04$62.16/sh−4,725→ 0 total
Disposition to Issuer
GENZYME CORP
Stock Option (right to buy)
2011-04-04$48.38/sh−4,000→ 0 total
Exercise/Conversion
GENZYME CORP
Genzyme common stock (GENZ)
2011-04-04+1,447→ 7,089 total
Disposition to Issuer
GENZYME CORP
Genzyme common stock (GENZ)
2011-04-04$74.00/sh−5,005→ 0 total
Disposition to Issuer
GENZYME CORP
Stock Option (right to buy)
2011-04-04$51.52/sh−4,340→ 0 total

Amello Jason

Recent Transactions

Companies

Recent Filings

Address